Health
Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein – News-Medical.Net
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19….
As the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), refuses to subside, the search for effective antivirals and therapeutics continues without respite. An encouraging paper published in the journal Nature Communicationson January 12, 2021, describes a promising new therapeutic antibody that potently neutralizes the virus.
SARS-CoV-2 has its own spike protein that interacts with the human angiotensin-converting enzyme 2 (ACE2)…
-
General19 hours agoJapan vs Wallabies Test live updates — blog, scores and stats from Tokyo
-
General23 hours agoBoy dies in foyer of Queensland police station after crash at Ormeau
-
Noosa News24 hours agoGout Gout breaks 400m meet record in his final GPS Championships for Ipswich Grammar School
-
General16 hours agoThai PM to ink Cambodia ceasefire deal but skips summit